tiprankstipranks
Protagonist Therapeutics (PTGX)
NASDAQ:PTGX
Holding PTGX?
Track your performance easily

Protagonist Therapeutics (PTGX) Cash flow

624 Followers

Protagonist Therapeutics Cash Flow

PTGX's free cash flow for Q3 2024 was $-28.64M. For the 2024 fiscal year, PTGX's free cash flow was decreased by $38.09M and operating cash flow was $-27.86M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ 230.29M$ -70.24M$ -108.14M$ -107.86M$ -72.48M$ -41.53M
Investing Cash Flow
$ -352.05M$ -39.26M$ 91.47M$ -15.86M$ -90.97M$ -53.71M
Financing Cash Flow
$ 22.35M$ 170.48M$ 18.84M$ 129.92M$ 247.63M$ 46.04M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 846.96M$ 186.95M$ 125.97M$ 123.89M$ 117.82M$ 33.47M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
----$ 438.00K$ 70.00K
Issuance Of Capital Stock
$ 8.00K$ 107.80M-$ 123.83M$ 213.30M$ 34.49M
Issuance Of Debt
-$ 24.30M$ 14.55M-$ 31.52M$ 44.26M
Repayment Of Debt
----$ -10.54M-
Free Cash Flow
$ 229.23M$ -70.84M$ -108.93M$ -108.97M$ -72.95M$ -42.49M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Protagonist Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis